NeuroGenetic Pharmaceuticals, Inc. — Form D
NeuroGenetic Pharmaceuticals, Inc. of DEL MAR, CA, a company, filed a Form D exempt-offering notice with the SEC on 2015-03-12. The offering totals $60K, of which $50K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-03-12
- Form: D
- Accession: 0001496298-15-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $60K
- Amount sold: $50K
- Remaining: $10K
- Investors: 1
- Date of first sale: 2015-02-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-235783
Issuer
- Name: NeuroGenetic Pharmaceuticals, Inc.
- CIK: 0001496298
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2009
- Address: 445 MARINE VIEW AVENUE, SUITE 101, DEL MAR, CA, 92014
- Phone: 858-461-4480
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| William T Comer | Director | Del Mar, CA |
| Barry T Quart | Director | Del Mar, CA |
| Tom T Reed | Director | Del Mar, CA |
| William T Comer | Executive Officer | Del Mar, CA |
Other filings by this issuer (4)
More